8-K - DiaMedica Therapeutics Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

and Exhibit 99.1 to this report shall not be deemed to be “filed” with the United States Securities and Exchange Commission for purposes of Section 18 of the Un

Regulation Fd

8.01

Other Events. As previously announced, DiaMedica requested and completed an in-person pre-IND meeting with the FDA for a planned study evaluating DM199 in pre-e

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description Manner of Filing 99.1 Press Release dated December 18, 2025 Furnished Electronically

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1